Treatment Compliance with Fixed-Dose Combination of Vildagliptin/Metformin in Patients with Type 2 Diabetes Mellitus Inadequately Controlled with Metformin Monotherapy: A 24-Week Observational Study

Table 3

Log regression model on compliance and confounding factors.

Variables		value	Exp()	95% CI for Exp()
				Lower	Upper
Treatment; (fixed versus free combination)	2,938	0.001	18,887	6,178	57,738
Medication recall visit 3	1,609	0.001	4,997	2,432	10,264
Swallowing difficulties; visit 3	−2,574	0.001	0,076	0,032	0,184
Constant	3,488	0.220	32,728